Global Hospital-acquired Urinary Tract Infection Testing Scope and Market Size
Hospital-acquired Urinary Tract Infection Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hospital-acquired Urinary Tract Infection Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
Assay kits and consumables
Instruments
Market segment by Application, split into
Hospitals and outpatient department
Diagnostics clinical laboratories
Based on regional and country-level analysis, the Hospital-acquired Urinary Tract Infection Testing market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Hospital-acquired Urinary Tract Infection Testing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
bioMérieux
Roche Diagnostics
Siemens Healthineer
ACON Laboratories
Abbott
ARKRAY
Beckman Coulter
Becton Dickinson
Bio-Rad
Cepheid
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hospital-acquired Urinary Tract Infection Testing Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Assay kits and consumables
1.2.3 Instruments
1.3 Market by Application
1.3.1 Global Hospital-acquired Urinary Tract Infection Testing Market Share by Application: 2020 VS 2026
1.3.2 Hospitals and outpatient department
1.3.3 Diagnostics clinical laboratories
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hospital-acquired Urinary Tract Infection Testing Market Perspective (2015-2026)
2.2 Global Hospital-acquired Urinary Tract Infection Testing Growth Trends by Regions
2.2.1 Hospital-acquired Urinary Tract Infection Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hospital-acquired Urinary Tract Infection Testing Historic Market Share by Regions (2015-2020)
2.2.3 Hospital-acquired Urinary Tract Infection Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hospital-acquired Urinary Tract Infection Testing Players by Market Size
3.1.1 Global Top Hospital-acquired Urinary Tract Infection Testing Players by Revenue (2015-2020)
3.1.2 Global Hospital-acquired Urinary Tract Infection Testing Revenue Market Share by Players (2015-2020)
3.2 Global Hospital-acquired Urinary Tract Infection Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hospital-acquired Urinary Tract Infection Testing Revenue
3.4 Global Hospital-acquired Urinary Tract Infection Testing Market Concentration Ratio
3.4.1 Global Hospital-acquired Urinary Tract Infection Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hospital-acquired Urinary Tract Infection Testing Revenue in 2019
3.5 Key Players Hospital-acquired Urinary Tract Infection Testing Area Served
3.6 Key Players Hospital-acquired Urinary Tract Infection Testing Product Solution and Service
3.7 Date of Enter into Hospital-acquired Urinary Tract Infection Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hospital-acquired Urinary Tract Infection Testing Breakdown Data by Type (2015-2026)
4.1 Global Hospital-acquired Urinary Tract Infection Testing Historic Market Size by Type (2015-2020)
4.2 Global Hospital-acquired Urinary Tract Infection Testing Forecasted Market Size by Type (2021-2026)
5 Hospital-acquired Urinary Tract Infection Testing Breakdown Data by Application (2015-2026)
5.1 Global Hospital-acquired Urinary Tract Infection Testing Historic Market Size by Application (2015-2020)
5.2 Global Hospital-acquired Urinary Tract Infection Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Hospital-acquired Urinary Tract Infection Testing Market Size (2015-2026)
6.2 North America Hospital-acquired Urinary Tract Infection Testing Market Size by Type (2015-2020)
6.3 North America Hospital-acquired Urinary Tract Infection Testing Market Size by Application (2015-2020)
6.4 North America Hospital-acquired Urinary Tract Infection Testing Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Hospital-acquired Urinary Tract Infection Testing Market Size (2015-2026)
7.2 Europe Hospital-acquired Urinary Tract Infection Testing Market Size by Type (2015-2020)
7.3 Europe Hospital-acquired Urinary Tract Infection Testing Market Size by Application (2015-2020)
7.4 Europe Hospital-acquired Urinary Tract Infection Testing Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Hospital-acquired Urinary Tract Infection Testing Market Size (2015-2026)
8.2 China Hospital-acquired Urinary Tract Infection Testing Market Size by Type (2015-2020)
8.3 China Hospital-acquired Urinary Tract Infection Testing Market Size by Application (2015-2020)
8.4 China Hospital-acquired Urinary Tract Infection Testing Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Hospital-acquired Urinary Tract Infection Testing Market Size (2015-2026)
9.2 Japan Hospital-acquired Urinary Tract Infection Testing Market Size by Type (2015-2020)
9.3 Japan Hospital-acquired Urinary Tract Infection Testing Market Size by Application (2015-2020)
9.4 Japan Hospital-acquired Urinary Tract Infection Testing Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Hospital-acquired Urinary Tract Infection Testing Market Size (2015-2026)
10.2 Southeast Asia Hospital-acquired Urinary Tract Infection Testing Market Size by Type (2015-2020)
10.3 Southeast Asia Hospital-acquired Urinary Tract Infection Testing Market Size by Application (2015-2020)
10.4 Southeast Asia Hospital-acquired Urinary Tract Infection Testing Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 bioMérieux
11.1.1 bioMérieux Company Details
11.1.2 bioMérieux Business Overview
11.1.3 bioMérieux Hospital-acquired Urinary Tract Infection Testing Introduction
11.1.4 bioMérieux Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2015-2020))
11.1.5 bioMérieux Recent Development
11.2 Roche Diagnostics
11.2.1 Roche Diagnostics Company Details
11.2.2 Roche Diagnostics Business Overview
11.2.3 Roche Diagnostics Hospital-acquired Urinary Tract Infection Testing Introduction
11.2.4 Roche Diagnostics Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2015-2020)
11.2.5 Roche Diagnostics Recent Development
11.3 Siemens Healthineer
11.3.1 Siemens Healthineer Company Details
11.3.2 Siemens Healthineer Business Overview
11.3.3 Siemens Healthineer Hospital-acquired Urinary Tract Infection Testing Introduction
11.3.4 Siemens Healthineer Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2015-2020)
11.3.5 Siemens Healthineer Recent Development
11.4 ACON Laboratories
11.4.1 ACON Laboratories Company Details
11.4.2 ACON Laboratories Business Overview
11.4.3 ACON Laboratories Hospital-acquired Urinary Tract Infection Testing Introduction
11.4.4 ACON Laboratories Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2015-2020)
11.4.5 ACON Laboratories Recent Development
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Hospital-acquired Urinary Tract Infection Testing Introduction
11.5.4 Abbott Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2015-2020)
11.5.5 Abbott Recent Development
11.6 ARKRAY
11.6.1 ARKRAY Company Details
11.6.2 ARKRAY Business Overview
11.6.3 ARKRAY Hospital-acquired Urinary Tract Infection Testing Introduction
11.6.4 ARKRAY Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2015-2020)
11.6.5 ARKRAY Recent Development
11.7 Beckman Coulter
11.7.1 Beckman Coulter Company Details
11.7.2 Beckman Coulter Business Overview
11.7.3 Beckman Coulter Hospital-acquired Urinary Tract Infection Testing Introduction
11.7.4 Beckman Coulter Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2015-2020)
11.7.5 Beckman Coulter Recent Development
11.8 Becton Dickinson
11.8.1 Becton Dickinson Company Details
11.8.2 Becton Dickinson Business Overview
11.8.3 Becton Dickinson Hospital-acquired Urinary Tract Infection Testing Introduction
11.8.4 Becton Dickinson Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2015-2020)
11.8.5 Becton Dickinson Recent Development
11.9 Bio-Rad
11.9.1 Bio-Rad Company Details
11.9.2 Bio-Rad Business Overview
11.9.3 Bio-Rad Hospital-acquired Urinary Tract Infection Testing Introduction
11.9.4 Bio-Rad Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2015-2020)
11.9.5 Bio-Rad Recent Development
11.10 Cepheid
11.10.1 Cepheid Company Details
11.10.2 Cepheid Business Overview
11.10.3 Cepheid Hospital-acquired Urinary Tract Infection Testing Introduction
11.10.4 Cepheid Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2015-2020)
11.10.5 Cepheid Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
bioMérieux
Roche Diagnostics
Siemens Healthineer
ACON Laboratories
Abbott
ARKRAY
Beckman Coulter
Becton Dickinson
Bio-Rad
Cepheid
*If Applicable.